MD1003-AMN MD1003 in Adrenomyeloneuropathy
Learn more about:
Related Clinical Trial
Baby Detect : Genomic Newborn Screening
A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN)
Study to Assess PXL065 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)
Study to Assess PXL770 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)
Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia
Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
Modeling Macrophages Activation Pattern in X-linked Adrenoleukodystrophy and Metachromatic Leukodystrophy
SMART-ALD – A New Lifestyle Intervention to Improve Quality of Life in Women With X-linked Adrenoleukodystrophy (X-ALD)
Quality of Life in Women With X-linked Adrenoleukodystrophy
A Clinical Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT)
Plasma Exchange With Albumin in AMN Patients
Stem Cell Transplant for Inborn Errors of Metabolism
Human Placental-Derived Stem Cell Transplantation
Precision Exercise in Children With Malignant Hemopathies
Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
HSCT for High Risk Inherited Inborn Errors
Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD)
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Safety, Pharmacokinetics and Pharmacodynamics of NV1205 in Pediatric Male Subjects With Adrenoleukodystrophy
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases
Effect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy
MD1003-AMN MD1003 in Adrenomyeloneuropathy
A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients.
Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)
A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants
Autologous Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy and Adrenoleukodystrophy
Repetitive Transcranial Magnetic Stimulation as Therapy in Hereditary Spastic Paraplegia and Adrenomyeloneuropathy
Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children
Early Diagnosis Of Childhood Cerebral ALD
Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy
Multi-center Clinical Study on the Diagnosis and Treatment Management of Rare Neurological Disease in Children
Expanded Access for Lorenzo’s Oil (GTO/GTE) in Adrenoleukodystrophy
Minnesota Adrenoleukodystrophy Registry Study (MARS) and Biobank
A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy
Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
The Effect of Bezafibrate on the Level of Very Long Chain Fatty Acids (VLCFA) in X-linked Adrenoleukodystrophy (X-ALD)
A Phase III Trial of Lorenzo’s Oil in Adrenomyeloneuropathy
Lentiviral Gene Therapy for X-ALD
MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD)
Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)
Newborn Screening for Adrenoleukodystrophy
A Study to Prospectively Assess Disease Progression in Male Children With X-ALD
Long-term Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product
Exercise Study of Function and Pathology for Women With X-linked Adrenoleukodystrophy